Abstract:Our aim was to investigate the action of Wnt5a in the development of chronic inflammation in polycystic ovary syndrome (PCOS), as well as explore the related molecular signaling pathways. This was a prospective study on the evaluation of Wnt5a expression change in ovarian granulosa cells of PCOS women and the analysis of cross-talk between Wnt5a signaling and inflammatory response using human granulosa-like tumor cell line, KGN. Mural granulosa cells from follicular fluids of 35 PCOS patients and 37 controls were collected during oocyte retrieval, mRNA was extracted and gene expressions were analyzed. Human KGN cells were cultured and treated with lipopolysaccharide (LPS, 1μg/ml) and distinct inhibitors of specific pathways (10μM). The following techniques were used: construction and transfection of Wnt5a expression vector, small RNA Interference of Wnt5a,gene expression analysis by quantitative RT-PCR, dual-luciferase reporter assay of NF-κB activation, flow cytometric assay of reactive oxygen species (ROS) levels, flow cytometric assay of cytokine expression, and western blot analysis. Our data demonstrated significant increased Wnt5a expression at both mRNA and protein levels in the mural granulosa cells of PCOS women compared with controls. Besides, Wnt5a mRNA level in granulosa cells of all subjects was positively correlated with the expression levels of inflammation-related genes, such as tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), IL6, IL8, monocyte chemotactic protein-1 (MCP-1), and C-reactive protein (CRP). Moreover, LPS stimulation dramatically increased Wnt5a expression in human KGN cells, and BAY-117082 (NF-κB inhibitor) treatment could suppress Wnt5a mRNA below the control level. In addition, Wnt5a overexpression upregulated pro-inflammatory cytokines and chemokines and promoted the intracellular ROS levels, IL-1β treatment (50 ng/ml) could further enhance Wnt5a mRNA level. Treatment with BAY-117082 or LY-294002 (PI3K inhibitor) could significantly inhibit Wnt5a-induced inflammation. Wnt5a acts as a pro-inflammatory factor in human ovarian granulosa cells. Increased expression of Wnt5a in PCOS upregulates inflammation mainly via PI3K/AKT/NF-κB signaling pathway, and induced pro-inflammatory cytokines could further enhance Wnt5a expression in NF-κB-dependent regulation, indicating a novel regulatory system in the development of chronic inflammation in PCOS.

PTX3 Impairs Granulosa Cell Function by Promoting the Secretion of Inflammatory Cytokines in M1 Macrophages Via the JAK Pathway

Elevated ovarian pentraxin 3 in polycystic ovary syndrome

[Research progress on the role of pentraxin 3 in polycystic ovary syndrome]

A Molecular Mechanism Underlying Ovarian Dysfunction of Polycystic Ovary Syndrome: Hyperandrogenism Induces Epigenetic Alterations in the Granulosa Cells

NLRP3 Inflammasome-dependent Pathway is Involved in the Pathogenesis of Polycystic Ovary Syndrome

Pentraxin 3 Levels in Young Women with and without Polycystic Ovary Syndrome (PCOS) in relation to the Nutritional Status and Systemic Inflammation

Impaired Granulosa Cells Promote Self-Damage By Regulating The Generation Of Macrophage In Polycystic Ovary Syndrome

The Casein Kinase 2α Promotes the Occurrence Polycystic Ovary Syndrome.

Hyperandrogenic environment regulates the function of ovarian granulosa cells by modulating macrophage polarization in PCOS

Purinergic receptor P2X7 activates NOX2/JNK signaling to participate in granulosa cell inflammation and apoptosis in polycystic ovary syndrome

The Release of Peripheral Immune Inflammatory Cytokines Promote an Inflammatory Cascade in PCOS Patients via Altering the Follicular Microenvironment

Testosterone-induced H3K27 deacetylation participates in granulosa cell proliferation suppression and pathogenesis of Polycystic Ovary Syndrome

C1QTNF6 participates in the pathogenesis of PCOS by affecting the inflammatory response of granulosa cells

Novel PGK1 Determines SKP2-dependent AR Stability and Reprograms Granular Cell Glucose Metabolism Facilitating Ovulation Dysfunction.

Up-Regulated Expression of WNT5a Increases Inflammation and Oxidative Stress Via PI3K/AKT/NF-κB Signaling in the Granulosa Cells of PCOS Patients

Long pentraxin 3 and vitamin D receptor mRNA expression pattern of cumulus granulosa cells isolated from PCOS oocytes at different stages of nuclear maturation

Serum granulosa cell-derived TNF-α promotes inflammation and apoptosis of renal tubular cells and PCOS-related kidney injury through NF-κB signaling

miR-4433a-3p promotes granulosa cell apoptosis by targeting peroxisome proliferator-activated receptor alpha and inducing immune cell infiltration in polycystic ovarian syndrome

Increased WNT5a expression upregulates inflammation via PI3K/AKT/NF-κB signaling in the granulosa cells of PCOS patients

CXCL12 and its receptors regulate granulosa cell apoptosis in PCOS rats and human KGN tumor cells

Interleukin-22 promotes proliferation and reverses LPS-induced apoptosis and steroidogenesis attenuation in human ovarian granulosa cells: implications for polycystic ovary syndrome pathogenesis